Photo of Boris Bershteyn

Boris Bershteyn

Partner, Skadden

212-735-3834boris.bershteyn@skadden.com

One Manhattan West
New York, NY 10001

View Firm Biography

Boris Bershteyn litigates complex antitrust and competition matters before trial and appellate courts and advises clients on regulatory and enforcement actions by government agencies and related internal investigations. He also represents businesses, sovereign entities, nonprofits and individuals in administrative, appellate and constitutional disputes.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 Leading Global Litigators 2026 International Litigation, Antitrust
The 2026 Lawdragon 500 Leading Global Antitrust & Competition Lawyers 2026 Antitrust & Competition Litigation, Appellate
The 2026 Lawdragon 500 Leading Lawyers in America 2026 Litigation, Antitrust, Appellate
The 2026 Lawdragon 500 Leading Litigators in America 2026 Complex Antitrust Investigations & Litigation; Appellate
The 2025 Lawdragon 500 Leading Global Litigators 2025 International Litigation, Antitrust
The 2025 Lawdragon 500 Leading Global Antitrust & Competition Lawyers 2025 Antitrust & Competition Litigation, Appellate
The 2025 Lawdragon 500 Leading Litigators in America 2025 Complex Antitrust Investigations & Litigation; Appellate
The 2024 Lawdragon 500 Leading Litigators in America 2024 Complex Antitrust Investigations & Litigation; Appellate
Lawdragon 500 Leading Litigators in America 2022 Complex Antitrust Investigations & Litigation; Appellate
The Lawdragon Global Litigation 500 2021 International Litigation, Antitrust

Bershteyn’s antitrust work has earned him a place on Lex Machina’s list of the top 10 most active antitrust attorneys in the country over the course of 2021-23. His antitrust litigation representations include:

  • JPMorgan Chase in:
    • antitrust class actions and other litigation alleging that foreign currency dealers conspired to manipulate benchmark currency exchange rates
    • antitrust class actions alleging a conspiracy in the trading of federal agency bonds
    • antitrust class actions and other litigation alleging a conspiracy among Visa, MasterCard and certain banks to set credit and debit card interchange fees and network rules
    • an antitrust class action alleging a conspiracy concerning ATM access fees (lead counsel on successful certiorari petition to U.S. Supreme Court)
    • an antitrust class action alleging a conspiracy to restrain competition in the credit default swaps market
  • Barclays Bank in:
    • an antitrust class action and enforcement litigation by the Federal Energy Regulatory Commission related to alleged manipulation of energy markets
    • antitrust class actions and related state False Claims Act litigations alleging anticompetitive activity related to variable rate debt obligations
  • Pioneer Natural Resources in antitrust class actions alleging a conspiracy among shale oil producers to reduce output
  • International Flavors & Fragrances in antitrust class actions alleging a conspiracy to restrain competition in the fragrance industry
  • HSBC in an antitrust class action alleging a conspiracy among dealers of Mexican government bonds
  • subsidiaries of Glencore in antitrust class actions concerning warehousing and trading of aluminum and zinc
  • Citigroup in an antitrust class action alleging a conspiracy among dealers of U.K. government bonds

Bershteyn’s recent administrative, appellate and constitutional representations include:

  • New York and Presbyterian Hospital in litigation against the federal government
  • the Republic of Argentina in proceedings before the U.S. Supreme Court concerning the scope of its foreign sovereign immunity
  • underwriters of Petrobras' bonds in an appeal of class certification in a securities action (class certification vacated by the Second Circuit)
  • California Association of Postsecondary Schools in litigation challenging a regulation by the Department of Education
  • Estée Lauder in appellate litigation involving putative consumer fraud class actions

In addition to having argued multiple appeals, Mr. Bershteyn maintains an active appellate amicus practice and has represented:

  • over 250 members of Congress in FDA v. Alliance for Hippocratic Medicine (U.S. Supreme Court 2023) (administrative law)
  • scholars of habeas corpus in Shinn v. Ramirez (U.S. Supreme Court 2021)
  • criminal law scholars in New York Rifle & Pistol Assn. v. Corlett (U.S. Supreme Court 2021)
  • 25 U.S. senators in Planned Parenthood v. Smith (Fifth Circuit 2019) (reproductive rights)
  • Intel Corporation in Helsinn Healthcare v. Teva Pharmaceuticals (U.S. Supreme Court 2018) (patent)
  • a coalition of businesses in Texas v. United States (U.S. Supreme Court 2016 and U.S. Court of Appeals for the Fifth Circuit 2015) (executive action on undocumented immigrants)
  • organizations of physicians and nurses in Whole Women’s Health v. Cole (U.S. Supreme Court 2016) (reproductive rights)
  • the American Public Health Association and Whitman-Walker Health in Obergefell v. Hodges (U.S. Supreme Court 2015) (same-sex marriage equality)